Incidence Studies
Because environment is a potent modulator of type 1 diabetes (T1D) gene penetrance, the T1DR will determine if the reported ability of a stock, and the particular genetic modification, to modulate T1D is retained under full barrier health status. Incidence studies will be performed to determine frequency and rate of mice of each sex, as well as NOD/LtJ.
In the past, NOD/LtJ mice in The Jackson Laboratory's production colonies developed diabetes at a 90-100% incidence over 30 weeks of age for females and a 40-60% diabetes incidence over 30-40 weeks of age for males. However, in 2006 the incidence was somewhat attenuated (females 65%, males 35%), very likely reflecting stress associated by campus wide blasting associated with construction and in 2008 the incidence is higher than we normally see (females 90%, males 85%), likely reflecting a room environment where the lights were on 24 hours a day for an undetermined amount of time, most likely several months. We are currently monitoring incidence studies for our colony of NOD/LtJ as well as other T1DR strains in our full barrier, sterile supply, specific-pathogen-free (SPF)) facility. These mice are housed in Pressurized Individually Ventilated (PIV) racks in a room dedicated to immuno-compromised stocks with minimal disturbance.
Incidence studies are available for the following strains:
- Stock No. 001976 - NOD/ltJ
- Stock No. 001289 - NOD/Lt
- Stock No. 002575 - NOD.129S7(B6)-Ifngtm1Ts /DvsJ
- Stock No. 003505 - NOD.B6-Prf1tm1Sdz /J
- Stock No. 004222 - NOD.129P2(B6)-Il4tm1Cgn/DvsJ
- Stock No. 004266 - NOD.Cg-Il10 tm1Cgn /DvsJ
- Stock No. 004291 - NOD.Cg-Il10tm1CgnIl4tm1Cgn/DvsJ
- Stock No. 004304 - NOD.CBALS.Tyr+/LtJ
- Stock No. 004352 - NOD.129S1(B6)-Ifngr2 tm1Pbro/DvsJ
- Stock No. 004444 - NOD.129P2(C)-Tcratm1Mjo/DoiJ
- Stock No. 004460 - NOD.Cg-Tg(TcraBDC2.5)1Doi Tg(TcrbBDC2.5)2Doi/DoiJ
- Stock No. 004639 - NOD.129S2(B6)-Igh-6tm1Cgn/DoiJ
- Stock No. 004519 - NOD.MRL(C3)-Faslpr/DoiJ
- Stock No. 004482 - NOD.B6-NK1.1 (NOD.B6-(D6Mit254-D6Mit339)/CarJ)
- Stock No. 004671 - NOD.129S2-Stat4tm1Gru/JbsJ
- Stock No. 004672 - NOD.129(Cg)-Stat6tm1Gru/JbsJ
- Stock No. 004696 - NOD.Cg-Tg(TcrLCMV)327Sdz/DvsJ
- Stock No. 004761 - NOD.129S2(B6)-Cd28tm1Mak/JbsJ
- Stock No. 004937 - NOD.Cg-Tg(Ins2-tTA)1Doi/DoiJ
- Stock No. 005018 - NOD.Cg-Tg(Igk-C/Igk-V125)1Jwt/JwtJ
- Stock No. 005036 - NOD.129S2(B6)-Ins2tm1Jja/GseJ
- Stock No. 005080 - NOD.Ica1tm1Mdos/MdosJ
- Stock No. 005144 - NOD.129(B6)-Ctla4tm1All/DoiJ
- Stock No. 005282- NOD.Mip-GFP - Histopathology, Immunoflorescence, Incidence studies, Glucose Tolerence test, Plasma Insulin
- Stock No. 005523 - NOD-Tg(ins2*y16A)3Ell/GseJ
- Stock No. 005524 - NOD.Cg-Tg(Ins2*Y16A)1Ell Ins1tm1Jja Ins2tm1Jja/GseJ
- Stock No. 005616 - NOD.C-(Ptprc-D1Mit262)/WehiJ (NOD.CD45)
- Stock No. 005352 - NOD.129-(D19Mit10-D19Mit54)/GseJ (NOD-Ins1 control)
- Stock No. 005353 - NOD.129-(D7Mit105-D7Mit223)/GseJ (NOD-Ins2 control)
- Stock No. 005516 - C.129S4-Cyb5r4tm1Hfb/HfbJ
- Stock No. 005525 - NOD.Cg-Tg(Ins2*Y16A)3Ell Ins1tm1Jja Ins2tm1Jja/GseJ (tg B:16 alanine, line F, Ins2 -/-, Ins1 -/-)
- Stock No. 005739 - NOD-Tg(H2-Ea-Ins2)1Wehi/WehiJ
- Stock No. 005868 - NOD.Cg-Tg(TcraTcrbNY8.3)1Pesa/DvsJ (NOD-Tcr NY8.3)
- Stock No. 005870 - NOD/ShiLt(Cg)-Tg(Ins2-GAD2)2LtJ (NOD.GAD65)
- Stock No. 005983 - NOD.129S4(B6)-Icam1tm1Jcgr/SmtnJ (NOD.ICAM1 original)
- Stock No. 006254 - NOD.Cg-Tg(Ins2-Ccl21b)2Cys/JbsJ (NOD.RIP-SLC)
- Stock No. 006303 - NOD.FVB-Tg(TcraBDC12-4.1)10Jos/GseJ (BDC12-4.1 TCR alpha 10)
- Stock No. 006304 - NOD.FVB-Tg(TcrbBDC12-4.1)82Gse/GseJ (NOD.BDC12-4.1 beta transgenic)
- Stock No. 006330 - NOD.129S2(B6)-Cd1d1/Cd1d2tm1Spb/SbwJ
- Stock No. 006345 - NOD.B6-Tg(IghelMD4)4Ccg/DvsJ (NOD.Ighel)
- Stock No. 006351 - NOD.129S4(B6)-Icam1tm1Jcgr /J (NOD.Icam1 clean)
- Stock No. 006604 - NOD/ShiLtDvs-Tg(HLA-A/H2-D/B2M)1DvsJ (NOD.HHD)
- Stock No. 006608 - NOD.Cg-Igh-6tm1Cgn Tg(IghelMD4)4Ccg/DvsJ
- Stock No. 006610 - NOD.B6-Tg(ML5sHEL)5Ccg/DvsJ (NOD.sHEL)
- Stock No. 006611 - NOD.129P2(B6)-B2mtm1Unc Tg(HLA/H2-D/B2M)1Dvs/DvsJ (NODB2m-/- HHD)
- Stock No. 006698 - NOD.Cg-IL4tm1Lky/JbsJ (NOD.4get)
- Stock No. 006777 - NOD/ShiLt-Tg(Ins2-Cd274)2Mdos/MdosJ (NOD.RIP-B7H1)
- Stock No. 006809 - NOD.B6-(D11Nds1-D11Mit41)/J (Idd sweep, Chr 1., Chr 11. and incidence study of the Idd4a congenic - comparison of stocks 005311 and 6809)
- Stock No. 007769 - NOD.FVB-Tg(Igh-6-Cd80)1Gjf/JbsJ (NOD.B7-1B Tg)
- Stock No. 007934 - NOD.B6(PL)-Idd3 C57BL/6J/MrkTacJ (NOD.B6-Idd3)
- Stock No. 008053 - NOD.L-(D11Mit314-D11Mit42)/McdfJ (NOD.Lc11)
- Stock No. 008057 - NOD.L-(D11Mit314-D11Mit33)/McdfJ (NOD.Lc11f)
- Stock No. 008061 - NOD.L-(D7Mit253-D7Mit242)/McdfJ (NOD.Lc7)
- Stock No. 008062 - NOD-Chr 1NZM2328/McdfJ (NOD.Zc1)
- Stock No. 008064 - NOD-Chr4NZM2328/McdfJ (NOD.Zc4)
- Stock No. 008173 - NOD.Cg-Tg(Ins1-EGFP)1Hara/QtngJ (NOD.MIP-GFP)
- Stock No. 008252 - NOD.129S4(B6)-Art2atm1Fkn Art2btm1Fkn/LtJ (NOD.Art2 -/-)
- Stock No. 008549 - NOD.FVB-Tg(Itgax-DTR/EGFP)57Lan/JdkJ (CD11c-DTR/NOD)
- Stock No. 008694 - NOD/ShiLt-Tg(Foxp3-EGFP/cre)1JbsJ (NOD.Foxp3-cre)
- Stock No. 010966 - NODCaj.129S2(B6)-H2-Ab1tm1Doi/LwnJ (NOD.Ab0)
Last Modified: August 01, 2012